Alnylam Pharmaceuticals, Inc.
$255.96
▲ +6.37
(+2.55%)
Volume: 1,077,065
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
45
- 21d momentum +7.1%
- MA aligned bearish
- RSI 56
🎯
Pullback
50
- +2.5% vs 20MA
💎
Value
58
- -48% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)55.9
MACD+0.615
MA trendBearish
ATR3.92%
21d mom.+7.1%
63d mom.-12.2%
vs 20MA+2.5%
RVOL(20)0.68×
52w low · 198
52w high · 496
-48.4% from 52-week high
20d support 224
· resistance 272
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$33.4B
PER41.33
PBR24.66
PSR6.95
EPS$6.04
ROE59.7%
ROA14.5%
Dividend yield0.00%
Debt/Equity0.75
EV/EBITDA31.01
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| +6.85% | +7.10% | -12.15% | -22.00% | -44.16% | -36.04% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -3.81%, daily vol 2.93%. Alnylam Pharmaceuticals, Inc. sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.